David Rickey, Director at CYTORI THERAPEUTICS, INC. (CYTX), bought 3,500 shares at $2.57 ($9K) on 2013-09-11, disclosed to the SEC on 2013-09-11.
Open-market purchase of $9k CYTX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| CYTX | BUY | 2015-08-31 | $17K | — | Filing → |
| CYTX | BUY | 2015-08-28 | $23K | — | Filing → |
| CYTX | BUY | 2015-08-24 | $19K | — | Filing → |